ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,418Medicare Part D Prescriptions Filled, Including Refills

Rank: 274 out of 2170

$741K Total Retail Price of All Prescriptions

Rank: 188 out of 2170

675 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 675 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 675 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 6,610 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 463 298 1 1
OMEPRAZOLE 406 240 2 2
LISINOPRIL 300 135 3 3
FUROSEMIDE 264 199 4 6
LEVOTHYROXINE SODIUM 254 132 5 5
HYDROCHLOROTHIAZIDE 228 137 6 9
POTASSIUM CHLORIDE 227 164 7 16
GABAPENTIN 202 111 8 14
METFORMIN HCL 199 109 9 8
AMLODIPINE BESYLATE 186 126 10 4
TRAMADOL HCL 186 104 10 18
WARFARIN SODIUM 181 147 12 15
BENZTROPINE MESYLATE 169 83 R 13 172
NIASPAN 166 63 14 103
CITALOPRAM HBR 165 102 15 19
CLOZAPINE 160 17 16 284
HYDROCODONE-ACETAMINOPHEN 157 79 S3 17 7
DONEPEZIL HCL 156 128 18 32
RISPERIDONE 141 99 19 73
METOPROLOL TARTRATE 138 73 20 10
MIRTAZAPINE 131 124 21 46
SERTRALINE HCL 130 99 22 25
ATENOLOL 130 118 22 23
ATORVASTATIN CALCIUM 125 50 24 12
METOPROLOL SUCCINATE 125 74 24 13
TAMSULOSIN HCL 115 85 26 33
NOVOLOG 109 75 27 98
SPIRIVA 100 68 28 49
RANITIDINE HCL 99 53 29 40
DIVALPROEX SODIUM 98 59 30 91
ZOLPIDEM TARTRATE 94 32 31 17
ADVAIR DISKUS 93 61 32 45
LEVETIRACETAM 92 90 33 109
DIVALPROEX SODIUM ER 88 24 34 189
LANTUS 86 59 35 51
TRAZODONE HCL 80 41 36 38
PANTOPRAZOLE SODIUM 80 54 36 39
CYMBALTA 77 55 38 44
NAMENDA 76 76 39 48
VALPROIC ACID 72 29 40 222
FENOFIBRATE 68 45 41 57
LACTULOSE 67 48 42 125
NYSTATIN 67 39 42 160
OXYCODONE HCL 66 31 S2 44 56
NEXIUM 65 29 45 22
ESCITALOPRAM OXALATE 65 29 45 75
QUETIAPINE FUMARATE 64 22 47 88
INSULIN SYRINGE 62 20 48 113
ISOSORBIDE MONONITRATE ER 60 58 49 50
IBUPROFEN 57 0 50 105
CLOPIDOGREL 54 48 51 37
CYCLOBENZAPRINE HCL 54 16 R 51 52
EXELON 52 47 53 119
FLUTICASONE PROPIONATE 52 27 53 30
PREDNISONE 50 26 55 41
ENALAPRIL MALEATE 50 47 55 64
FINASTERIDE 50 45 55 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.